Skip to content

US · MD · MEDICAL - CARE FACILITIES

Pediatrix Medical Group, Inc. (MD) intrinsic value and stock valuation

$30.22as of 2026-11-21 · Mkt cap 2.13B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Pediatrix Medical Group, Inc. DCF and intrinsic value

InvestorsCraft values MD with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from MD’s statements →

Pediatrix Medical Group, Inc. Graham Number

Graham Number: $21.05d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Sunrise, FL 33323 pediatrix.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$1.91B+2% 5y CAGRd
20112025
Net income
$165.4M
20112025
Free cash flow
$252.6M+7.5% 5y CAGRd
20112025
Total equity
$865.9M+3% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$1.91B$2.01B$1.99B$1.97B$1.91B
Operating income$231.1M-$-68.71M$7.32M$172.7M$202.9M
Net income$165.4M-$-99.07M-$-60.41M$66.3M$131M
EPSd$1.94M-$-1.19M-$-734.91K$788.5K$1.52M
Operating cash flow$271.1M$206.6M$137.3M$166.9M$76.7M
Capital expenditure-$-18.46M-$-22.02M-$-33.33M-$-29.71M-$-32.25M
Free cash flow$252.6M$184.6M$104M$137.2M$44.5M
Total assets$2.25B$2.15B$2.22B$2.35B$2.72B
Total debt$660.3M$662.3M$701.7M$717.1M$1.07B
Net debt$285.1M$432.4M$628.4M$707.3M$678.4M
Total equity$865.9M$764.9M$849.1M$891.6M$896.7M
Cash and short-term investments$499.7M$348.5M$177.7M$103.1M$487.1M
Income statement
20252024202320222021
Revenue$1.91B$2.01B$1.99B$1.97B$1.91B
Cost of revenue$1.44B$1.56B$1.57B$1.5B$1.4B
Gross profit$471.9M$454.3M$421.6M$467M$513.2M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$240.8M$238.4M$227.5M$231.4M$263.4M
Other expenses$0.00$284.6M$186.7M$63M$47M
Operating expenses$240.8M$523.1M$414.2M$294.4M$310.3M
Cost and expenses$1.68B$2.08B$1.99B$1.8B$1.71B
Interest income$19.1M$0.00$0.00$0.00$0.00
Interest expense$36M$40.7M$42.1M$39.7M$68.7M
Depreciation and amortization$21.8M$32.2M$36.2M$35.6M$32.2M
Ebitda$274.2M-$-28.37M$29.9M$156.7M$236.1M
Operating income$231.1M-$-68.71M$7.32M$172.7M$202.9M
Total other income/expenses, net-$-14.65M-$-32.63M-$-55.68M-$-91.32M-$-67.69M
Income before tax$216.4M-$-101.34M-$-48.36M$81.4M$135.2M
Income tax expense$51M-$-2.27M$12.1M$18.8M$27.2M
Net income$165.4M-$-99.07M-$-60.41M$66.3M$131M
Weighted average shares outstanding$85.3M$83.3M$84M$83M$86.4M
Weighted average diluted shares outstanding$85.3M$83.3M$82.2M$84.1M$86.4M
Balance sheet
20252024202320222021
Cash and short-term investments$499.7M$348.5M$177.7M$103.1M$487.1M
Net receivables$242.3M$272.6M$279.9M$296.8M$316M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$763.5M$639.6M$483.5M$428M$840.6M
Property, plant and equipment, net$73.5M$78.4M$145.9M$140.2M$135.6M
Goodwill and intangible assets$1.28B$1.25B$1.41B$1.55B$1.53B
Long-term investments$20.8M$0.00$0.00$0.00$0.00
Total non-current assets$1.48B$1.51B$1.74B$1.92B$1.88B
Total assets$2.25B$2.15B$2.22B$2.35B$2.72B
Accounts payable$37.2M$46.4M$34.6M$31.9M$36.7M
Short-term debt$38.4M$33.3M$36M$36.5M$22.2M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$458.9M$434.1M$389M$427M$427.4M
Long-term debt$621.9M$629.1M$665.7M$680.6M$1.04B
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$921.9M$953.7M$981.8M$1.03B$1.4B
Capital lease obligations$27.3M$50M$77.6M$76.9M$63.6M
Total liabilities$1.38B$1.39B$1.37B$1.46B$1.83B
Common stock$830K$860K$840K$830K$860K
Retained earnings-$-83.15M-$-248.54M-$-149.47M-$-89.06M-$-155.39M
Accumulated other comprehensive income (loss)$610K-$-1.07M-$-2.21M-$-3.73M$1.32M
Total equity$865.9M$764.9M$849.1M$891.6M$896.7M
Total investments$145.3M$118.6M$104.5M$93.2M$99.7M
Total debt$660.3M$662.3M$701.7M$717.1M$1.07B
Net debt$285.1M$432.4M$628.4M$707.3M$678.4M
Cash flow statement
20252024202320222021
Net income$165.4M-$-99.07M-$-60.41M$62.6M$108M
Depreciation and amortization$21.8M$33.2M$36.2M$35.6M$32.2M
Stock-based compensation$18.1M$11.9M$12.3M$16.1M$19M
Change in working capital$41.8M$88.2M-$-11.63M$31.8M-$-23.36M
Accounts receivable$30.6M$10.3M$26.3M-$-5.54M-$-72.73M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$28.3M$51.1M-$-11.92M$420K$21.3M
Net cash provided by operating activities$271.1M$206.6M$137.3M$166.9M$76.7M
Investments in property, plant and equipment-$-18.46M-$-22.02M-$-33.33M-$-29.71M-$-32.25M
Acquisitions, net$6.8M-$-8.17M-$-6.67M-$-28.17M-$-29.93M
Net cash used for investing activities-$-18.3M-$-35.41M-$-48.18M-$-56.95M-$-53.07M
Common stock issued$3.18M$3.64M$4.91M$5.4M$6.85M
Common stock repurchased-$-86.68M-$-1.7M-$-920K-$-88.51M-$-4.72M
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities-$-107.49M-$-14.48M-$-25.71M-$-487.55M-$-760.12M
Net change in cash$145.3M$156.7M$63.4M-$-377.57M-$-736.45M
Cash at end of period$375.2M$229.9M$73.3M$9.82M$387.4M
Operating cash flow$271.1M$206.6M$137.3M$166.9M$76.7M
Capital expenditure-$-18.46M-$-22.02M-$-33.33M-$-29.71M-$-32.25M
Free cash flow$252.6M$184.6M$104M$137.2M$44.5M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Pediatrix Medical Group, Inc.

        Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonatal care to critically ill or prematurely born infants within hospital units, staffed by expert neonatal subspecialists and advanced practice clinicians. For pregnant individuals and their developing babies, Pediatrix provides comprehensive maternal-fetal medicine services in both clinical and inpatient settings, involving specialists such as maternal-fetal medicine physicians, obstetricians, and genetic counselors. Furthermore, the group delivers pediatric cardiology services, addressing both congenital and acquired heart conditions in patients ranging from the fetal stage through adulthood, under the care of dedicated pediatric cardiologists. Beyond these core areas, Pediatrix extends its expertise to various other pediatric subspecialties, including those requiring intensivists, surgeons, and ophthalmologists, and supplies vital support to hospital departments like emergency rooms and labor and delivery units. Established in 1979 in Sunrise, Florida, and formerly known as MEDNAX, Inc. until its renaming in July 2022, the company managed a network of approximately 2,700 physicians as of February 2022.

        CEO
        Mark S. Ordan
        Employees
        4.12K
        Beta
        0.66

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of Pediatrix Medical Group, Inc. (MD)?

        Pediatrix Medical Group, Inc. (MD) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is MD undervalued?

        MD trades at a price of $30.22 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.